Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Cocrystal Pharma, Inc. (COCP) had Return on Investments of -31.50% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.30M |
|
-- |
|
-- |
|
$2.34M |
|
$-2.34M |
|
$0.04M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.30M |
|
$-2.34M |
|
$-2.32M |
|
10.17M |
|
10.17M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$8.83M |
|
$0.13M |
|
$1.83M |
|
$10.66M |
|
$1.93M |
|
-- |
|
$1.42M |
|
$3.35M |
|
$7.30M |
|
$7.30M |
|
$7.30M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-2.94M |
|
-- |
|
-- |
|
$9.94M |
|
$7.00M |
|
$-2.94M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.50% |
|
-31.50% |
|
-21.59% |
|
|
Return on Investments |
-31.50% |
$0.72 |
|
$-0.29 |
|
$-0.29 |
|